Table 2.
Antibodies for mass cytometry.
| Targets | Metals | Clones | Suppliers | References |
|---|---|---|---|---|
| CD45 | 89Y | HI30 | Fluidigm | 3089003B |
| CD38 | 112Cd | HIT2 | Life technologies | Q22150 |
| HLA-DR | 115 In | L243 | Ozyme | BLE307651 |
| IL-1β | 141 Pr | 8516 | R & D Systems | MAB201-100 |
| CD27 | 142 Nd | O323 | Ozyme | BLE302802 |
| CD123 | 143 Nd | 6H6 | Ozyme | BLE306002 |
| CD4 | 145 Nd | RPA-T4 | Ozyme | BLE300516 |
| CD8 | 146 Nd | RPT-T8 | Ozyme | BLE301018 |
| CD86 | 148 Nd | FM95 | Miltenyi | 130-095-212 |
| IL-17 | 151 Eu | CZ8-23G1 | Miltenyi | 130-095-212 |
| CD304 (BDCA4) | 152 Sm | AD5-17F6 | Miltenyi | 130-095-212 |
| CD11C | 153 Eu | Bu15 | Ozyme | BLE337202 |
| Il-6 | 154 Sm | MG2-13A5 | Miltenyi | 130-095-212 |
| CD279 (PD-1) | 156 Gd | PD1.3.1.3 | Miltenyi | 130-095-212 |
| CD14 | 160 Gd | M5E2 | Ozyme | BLE301810 |
| IFNγ | 161 Dy | 45-15 | Miltenyi | 130-095-212 |
| CD185 (CXCR5) | 162 Dy | REA103 | Miltenyi | 130-095-212 |
| CCR7 (CD197) | 163 Dy | REA108 | Miltenyi | 130-095-212 |
| IFN α2 | 165 Ho | 3C5 | R & D Systems | H00003440-M27 |
| TNF-α | 166 Er | cA2 | Miltenyi | 130-095-212 |
| CD56 | 168 Er | HCD56 | Ozyme | BLE318324 |
| CD45RA | 169 Tm | T6D11 | Miltenyi | 130-095-212 |
| CD3 | 170 Er | BW264/56 | Miltenyi | 130-095-212 |
| IgM | 172 Yb | PJ2-22H3 | Miltenyi | 130-095-212 |
| IgD | 174 Yb | IgD26 | Miltenyi | 130-095-212 |
| CXCL10 | 175 Lu | REA334 | Miltenyi | 130-095-212 |
| CD19 | 176 Yb | LT19 | Miltenyi | 130-108-029 |
| CD278 (ICOS) | 198 Pt | REA183 | Miltenyi | 130-095-212 |
| CD16 | 209 Bi | 3G8 | Fluidigm | 3209002B |